Other missing data are on-ECMO therapies, such as adjunctive treatment strategy (e.g., steroids, antiviral drugs, convalescent plasma, interleukin-6 receptor monoclonal antibodies, prostaglandin, and hydroxychloroquine), anticoagulation trends, blood products, other co-infections, and antibiotics use. The gene discussed is IL6R; the disease is coinfection.